Indian Pennywort (
Centella asiatica L.,) is an important tropical medicinal plant belongs to the family Apiaceae with a somatic chromosome number 2n=18. The plant is native to South East Asian countries including India, Sri Lanka, China and Malaysia as well as South Africa and has pantropical in distribution. It occurs throughout India in moist places from plains to hill ranges up to 2000 m (
Mukherjee and Constance, 1993). The whole herb is economically important and its biological effects have been attributed to the existence of major triterpene derivatives including madecassoside, asiaticoside, madecassic and asiatic acid
(Schaneberg et al., 2003). The use of
Centella asiatica L. in food and beverages has increased over the years due to its health benefits such as anti-inflammatory, cardio protective, wound healing, memory enhancing and antioxidant properties. Further, it is also considered as an effective antidiabetic, antimicrobial and antiproliferative herb. The plant is also used in cosmetic masks and creams to increase the synthesis of collagen and the firming up of the skin. Owing to its innumerable phytopharmaceutical properties, the herb is used in many
Ayurvedic formulations and products including Mentat and
Mandukaparni (Memory booster), Geriforte (Stress care), Abana (Heart care), Weight loss tea, Nourishing skin cream, Organic baby skin care, Gotu Kola and Germanium moisturizer, Geriforte vet and Anxocare (Animal health care)
etc.
According to the reports of Export and Import Bank of India,
Centella asiatica L. is one of the important medicinal plants in the international trade
(Singh et al., 2010). Also, National Medicinal Plant Board (NMPB) reported that the total estimated annual trade of
C.,
asiatica L. in the Indian market was between 500-1000 MT, with an average price of fresh herb ranging between 0.40-0.50 US dollar/kg traded annually
(Prasad et al., 2019). However, the wild stock of this plant species has been markedly depleted, because of its large scale and unrestricted exploitation coupled with limited cultivation and insufficient attempts for its replacement. Further, it is listed as threatened plant species
(Gowthami et al., 2021) by the International Union for Conservation of Nature (IUCN) with threat category of LC (Least concern).
The Indian Pennywort is treated as threatened species due to indiscriminate collections from the wild. To meet the industrial requirement on sustainable basis, commercial cultivation of
Centella asiatica L. is the only solution as this is an important upcoming medicinal herb with pharmaceutical, neutraceutical and cosmoceutical properties medicinal plants. Based on a wide range of industrial applications, these medical constituents have a high demand
(Nav et al., 2021) in the global market (US$900 billion per year).
Increased production is possible by bringing more area under cultivation and by increasing the productivity through crop improvement programmes and cultivation on sound scientific line. Genetic improvement and development of high yielding varieties in
Centella asiatica L. largely depend on the genetic variability in the species. Identification of superior germplasm accessions for higher herbage yield and tri-terpenoid contents can promote its cultivation which would benefit the drug industry in terms of higher dry recovery with higher desirable chemical contents.
The sustainable and commercial cultivation of
Centella asiatica L. largely depends on the availability of elite genotypes and developing such genotypes through planned, systematic and organized crop improvement programme. Further, sustained supply of quality raw material to the industry is possible only through cultivation of elite genotypes with high potency as the natural resources are dwindling. Increased productivity will also facilitate the international trade with high potency raw material at a reasonable cost as both producers and consumers are benefitted.